- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.70 Å
- Oligo State
- homo-tetramer
- Ligands
- 8 x HDV: 9-{2-deoxy-2-fluoro-5-O-[(R)-hydroxy{[(S)-hydroxy(phosphonooxy)phosphoryl]oxy}phosphoryl]-beta-D-arabinofuranosyl}-2-me thyl-9H-purin-6-amine(Non-covalent)
- 4 x GTP: GUANOSINE-5'-TRIPHOSPHATE(Non-covalent)
GTP.2: 16 residues within 4Å:- Chain A: Y.79, V.80, V.302, R.375, K.379
- Chain C: K.447
- Chain D: K.40, V.41, I.42, I.60, D.61, Q.66, R.69, F.89
- Ligands: HDV.29, MG.39
25 PLIP interactions:10 interactions with chain D, 9 interactions with chain A, 6 interactions with chain C- Hydrogen bonds: D:V.41, D:Q.66, D:R.69, A:R.375
- Water bridges: D:K.40, D:D.61, D:Q.66, A:K.301, A:K.379, A:K.379, A:Y.380, C:K.447, C:K.447, C:K.447, C:K.447
- Salt bridges: D:K.40, D:K.40, D:K.40, D:D.61, A:R.375, A:K.379, A:K.379, C:K.447, C:K.447
- pi-Cation interactions: A:R.375
GTP.4: 15 residues within 4Å:- Chain A: K.40, V.41, I.42, I.60, D.61, Q.66, R.69, F.89
- Chain B: K.447
- Chain D: Y.79, V.80, V.302, R.375
- Ligands: HDV.18, MG.19
28 PLIP interactions:8 interactions with chain D, 14 interactions with chain A, 6 interactions with chain B- Hydrogen bonds: D:R.375, A:V.41, A:Q.66, A:R.69
- Water bridges: D:K.301, D:K.301, D:K.379, A:K.40, A:K.40, A:K.40, A:K.40, A:K.40, A:D.61, A:Q.66, B:K.447, B:K.447, B:K.447, B:K.447
- Salt bridges: D:R.375, D:K.379, D:K.379, A:K.40, A:K.40, A:K.40, A:D.61, B:K.447, B:K.447
- pi-Cation interactions: D:R.375
GTP.16: 16 residues within 4Å:- Chain B: Y.79, V.80, V.302, R.375, K.379
- Chain C: K.40, V.41, I.42, I.60, D.61, Q.66, R.69, F.89
- Chain D: K.447
- Ligands: HDV.40, MG.41
23 PLIP interactions:6 interactions with chain B, 12 interactions with chain C, 5 interactions with chain D- Hydrogen bonds: B:R.375, C:V.41, C:Q.66, C:R.69
- Water bridges: B:K.379, C:K.40, C:K.40, C:K.40, C:K.40, C:D.61, D:K.447, D:K.447, D:K.447
- Salt bridges: B:R.375, B:K.379, B:K.379, C:K.40, C:K.40, C:K.40, C:D.61, D:K.447, D:K.447
- pi-Cation interactions: B:R.375
GTP.31: 16 residues within 4Å:- Chain A: K.447
- Chain B: K.40, V.41, I.42, I.60, D.61, Q.66, R.69, F.89
- Chain C: Y.79, V.80, V.302, R.375, K.379
- Ligands: HDV.3, MG.17
24 PLIP interactions:11 interactions with chain B, 9 interactions with chain C, 4 interactions with chain A- Hydrogen bonds: B:V.41, B:Q.66, B:R.69, C:R.375
- Water bridges: B:K.40, B:K.40, B:K.40, B:K.40, C:K.301, C:K.301, C:K.379, C:K.379, A:K.447, A:K.447
- Salt bridges: B:K.40, B:K.40, B:K.40, B:D.61, C:R.375, C:K.379, C:K.379, A:K.447, A:K.447
- pi-Cation interactions: C:R.375
- 10 x MG: MAGNESIUM ION(Non-covalent)
MG.5: 2 residues within 4Å:- Chain A: K.236
- Ligands: HDV.1
No protein-ligand interaction detected (PLIP)MG.6: 6 residues within 4Å:- Chain A: R.88, H.91, R.130, N.131, D.235
- Ligands: HDV.1
3 PLIP interactions:3 interactions with chain A- Metal complexes: A:H.91, A:D.235, A:D.235
MG.17: 4 residues within 4Å:- Chain A: K.447
- Chain B: K.40
- Ligands: HDV.3, GTP.31
No protein-ligand interaction detected (PLIP)MG.19: 4 residues within 4Å:- Chain A: K.40
- Chain B: K.447
- Ligands: GTP.4, HDV.18
No protein-ligand interaction detected (PLIP)MG.20: 3 residues within 4Å:- Chain B: D.233, K.236
- Ligands: HDV.15
No protein-ligand interaction detected (PLIP)MG.21: 6 residues within 4Å:- Chain B: R.88, H.91, R.130, N.131, D.235
- Ligands: HDV.15
3 PLIP interactions:3 interactions with chain B- Metal complexes: B:H.91, B:D.235, B:D.235
MG.32: 2 residues within 4Å:- Chain C: K.236
- Ligands: HDV.30
No protein-ligand interaction detected (PLIP)MG.39: 3 residues within 4Å:- Chain D: K.40
- Ligands: GTP.2, HDV.29
No protein-ligand interaction detected (PLIP)MG.41: 4 residues within 4Å:- Chain C: K.40
- Chain D: K.447
- Ligands: GTP.16, HDV.40
No protein-ligand interaction detected (PLIP)MG.43: 3 residues within 4Å:- Chain D: D.233, K.236
- Ligands: HDV.42
No protein-ligand interaction detected (PLIP)- 23 x NA: SODIUM ION(Non-functional Binders)
NA.7: 4 residues within 4Å:- Chain A: R.257, F.258, F.261, E.279
Ligand excluded by PLIPNA.8: 4 residues within 4Å:- Chain A: G.281, N.282, D.285
- Chain C: R.296
Ligand excluded by PLIPNA.9: 4 residues within 4Å:- Chain A: Y.380, V.381, G.382, D.507
Ligand excluded by PLIPNA.10: 7 residues within 4Å:- Chain A: K.391, I.392, K.393, R.394, Y.397, N.428, Q.472
Ligand excluded by PLIPNA.11: 3 residues within 4Å:- Chain A: Q.371
- Ligands: NA.12, SIN.14
Ligand excluded by PLIPNA.12: 2 residues within 4Å:- Ligands: NA.11, SIN.14
Ligand excluded by PLIPNA.22: 3 residues within 4Å:- Chain B: F.258, E.279, N.282
Ligand excluded by PLIPNA.23: 4 residues within 4Å:- Chain B: G.281, N.282, D.285
- Chain D: R.296
Ligand excluded by PLIPNA.24: 4 residues within 4Å:- Chain B: P.63, S.171, N.172
- Chain C: Y.374
Ligand excluded by PLIPNA.25: 2 residues within 4Å:- Chain B: W.209, E.216
Ligand excluded by PLIPNA.33: 3 residues within 4Å:- Chain C: Q.195, Y.222, S.226
Ligand excluded by PLIPNA.34: 3 residues within 4Å:- Chain B: N.349, L.352
- Chain C: N.349
Ligand excluded by PLIPNA.35: 4 residues within 4Å:- Chain A: H.288
- Chain C: Y.284, D.285, L.465
Ligand excluded by PLIPNA.36: 2 residues within 4Å:- Chain A: K.301
- Chain C: K.278
Ligand excluded by PLIPNA.44: 3 residues within 4Å:- Chain D: Q.195, Y.222, S.226
Ligand excluded by PLIPNA.45: 3 residues within 4Å:- Chain A: N.349, L.352
- Chain D: N.349
Ligand excluded by PLIPNA.46: 5 residues within 4Å:- Chain B: G.248, I.249
- Chain C: N.43
- Chain D: D.254
- Ligands: HDV.40
Ligand excluded by PLIPNA.47: 4 residues within 4Å:- Chain D: P.185, E.186, I.189, C.190
Ligand excluded by PLIPNA.48: 1 residues within 4Å:- Chain D: A.149
Ligand excluded by PLIPNA.49: 5 residues within 4Å:- Chain A: Y.356
- Chain D: N.349, I.350, E.353
- Ligands: NA.51
Ligand excluded by PLIPNA.50: 2 residues within 4Å:- Chain D: A.326, E.341
Ligand excluded by PLIPNA.51: 5 residues within 4Å:- Chain D: I.321, E.322, I.323, E.353
- Ligands: NA.49
Ligand excluded by PLIPNA.52: 3 residues within 4Å:- Chain D: R.118, E.187
- Ligands: TCE.56
Ligand excluded by PLIP- 7 x GLY: GLYCINE(Non-covalent)
GLY.13: 3 residues within 4Å:- Chain A: R.229, H.441, R.455
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:H.441
- Salt bridges: A:R.229, A:R.272, A:H.441, A:R.455
GLY.26: 3 residues within 4Å:- Chain B: Q.371, N.376, F.378
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:N.376
GLY.27: 3 residues within 4Å:- Chain B: Q.371, Y.374, N.376
5 PLIP interactions:2 Ligand-Ligand interactions, 3 interactions with chain B- Hydrogen bonds: G.27, G.27, B:Q.371, B:Q.371, B:N.376
GLY.37: 5 residues within 4Å:- Chain A: R.295, R.296
- Chain C: G.281, N.282, D.285
6 PLIP interactions:3 interactions with chain C, 2 Ligand-Ligand interactions, 1 interactions with chain A- Water bridges: C:G.281, C:G.281, C:D.285
- Hydrogen bonds: G.37, G.37
- Salt bridges: A:R.296
GLY.53: 6 residues within 4Å:- Chain B: S.292, R.295, R.296
- Chain D: G.281, N.282, D.285
7 PLIP interactions:1 Ligand-Ligand interactions, 1 interactions with chain B, 5 interactions with chain D- Hydrogen bonds: G.53, B:R.296, D:G.281, D:N.282
- Water bridges: D:G.281, D:G.281, D:G.281
GLY.54: 1 residues within 4Å:- Chain D: K.212
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:Y.211, D:K.212
- Water bridges: D:K.212
GLY.55: 6 residues within 4Å:- Chain D: S.116, R.118, D.119, R.214, K.218
- Ligands: TCE.56
9 PLIP interactions:9 interactions with chain D- Hydrogen bonds: D:S.116
- Water bridges: D:R.118, D:R.214, D:K.218, D:K.218, D:K.218
- Salt bridges: D:R.118, D:R.214, D:K.218
- 2 x SIN: SUCCINIC ACID(Non-covalent)
SIN.14: 6 residues within 4Å:- Chain A: Q.371, N.376, F.378, K.479
- Ligands: NA.11, NA.12
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.376
- Water bridges: A:V.481
SIN.38: 6 residues within 4Å:- Chain C: I.368, Q.371, N.376, F.378, K.479, V.481
4 PLIP interactions:4 interactions with chain C- Hydrophobic interactions: C:Q.371, C:F.378
- Hydrogen bonds: C:N.376, C:K.479
- 1 x PO4: PHOSPHATE ION(Non-functional Binders)
- 1 x TCE: 3,3',3''-phosphanetriyltripropanoic acid(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Knecht, K.M. et al., The structural basis for cancer drug interactions with the catalytic and allosteric sites of SAMHD1. Proc. Natl. Acad. Sci. U.S.A. (2018)
- Release Date
- 2018-10-10
- Peptides
- Deoxynucleoside triphosphate triphosphohydrolase SAMHD1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
DB
CC
BD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.70 Å
- Oligo State
- homo-tetramer
- Ligands
- 8 x HDV: 9-{2-deoxy-2-fluoro-5-O-[(R)-hydroxy{[(S)-hydroxy(phosphonooxy)phosphoryl]oxy}phosphoryl]-beta-D-arabinofuranosyl}-2-me thyl-9H-purin-6-amine(Non-covalent)
- 4 x GTP: GUANOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 10 x MG: MAGNESIUM ION(Non-covalent)
- 23 x NA: SODIUM ION(Non-functional Binders)
- 7 x GLY: GLYCINE(Non-covalent)
- 2 x SIN: SUCCINIC ACID(Non-covalent)
- 1 x PO4: PHOSPHATE ION(Non-functional Binders)
- 1 x TCE: 3,3',3''-phosphanetriyltripropanoic acid(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Knecht, K.M. et al., The structural basis for cancer drug interactions with the catalytic and allosteric sites of SAMHD1. Proc. Natl. Acad. Sci. U.S.A. (2018)
- Release Date
- 2018-10-10
- Peptides
- Deoxynucleoside triphosphate triphosphohydrolase SAMHD1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
DB
CC
BD
A